Values First Advisors’s Emergent Biosolutions EBS Stock Holding History

Values First Advisors’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.53M	Sell	301,488 -6,392	-2%	-$53.5K	1.15%	20
2026 Q1	$2.56M	Buy	307,880 +2,834	+0.9%	+$29.4K	1.33%	14
2025 Q4	$3.77M	Sell	305,046 -62,873	-17%	-$674K	1.96%	8
2025 Q3	$3.25M	Sell	367,919 -8,084	-2%	-$62.9K	1.74%	10
2025 Q2	$2.4M	Buy	376,003 +756	+0.2%	+$4.33K	1.31%	13
2025 Q1	$1.81M	Sell	375,247 -1,445	-0.4%	-$12K	1.06%	24
2024 Q4	$3.6M	Sell	376,692 -79,516	-17%	-$730K	1.98%	8
2024 Q3	$3.81M	Sell	456,208 -9,943	-2%	-$90.4K	2.07%	6
2024 Q2	$3.18M	Sell	466,151 -3,936	-0.8%	-$16.9K	1.9%	6
2024 Q1	$1.19M	Buy	470,087 +162,195	+53%	+$366K	0.7%	44
2023 Q4	$739K	Buy	307,892 +155,193	+102%	+$365K	0.45%	74
2023 Q3	$519K	Buy	152,699 +101,796	+200%	+$564K	0.34%	91
2023 Q2	$374K	Buy	50,903 +1,282	+3%	+$11.9K	0.23%	113
2023 Q1	$514K	Buy	49,621 +15,679	+46%	+$190K	0.33%	86
2022 Q4	$401K	Buy	33,942 +19,929	+142%	+$308K	0.28%	97
2022 Q3	$294K	Buy	+14,013	New	+$390K	0.21%	110
2022 Q2	–	Sell	-6,477	Closed	-$266K	–	161
2022 Q1	$266K	Buy	6,477 +976	+18%	+$43K	0.17%	133
2021 Q4	$239K	Buy	+5,501	New	+$249K	0.14%	144
2021 Q3	–	Sell	-3,593	Closed	-$226K	–	150
2021 Q2	$226K	Buy	+3,593	New	+$231K	0.15%	135

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

OHA

Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Values First Advisors's EBS Position: Q2 2026 in Review

Values First Advisors reduced its Emergent Biosolutions (EBS) stake by 2.1% in Q2 2026, selling an estimated $53.5K and leaving 301,488 shares worth $2.53M. The position accounts for 1.15% of the portfolio, ranked #20.

Values First Advisors first reported a position in EBS in Q2 2021 and has held it in 19 quarters since. The position peaked at $3.81M in Q3 2024. 194 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

Values First Advisors held 301,488 shares of Emergent Biosolutions worth $2.53M as of Q2 2026.
Values First Advisors sold 6,392 Emergent Biosolutions shares in Q2 2026, an estimated $53.5K.
Emergent Biosolutions made up 1.15% of Values First Advisors's portfolio in Q2 2026, its #20 holding.
Values First Advisors first reported a position in Emergent Biosolutions in Q2 2021 and has held it in 19 quarters since.
Values First Advisors's Emergent Biosolutions position peaked at $3.81M in Q3 2024.
194 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Values First Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.